SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,680,000 | +308.7% | 68,740 | +174.8% | 0.08% | +310.0% |
| Q4 2019 | $2,858,000 | +525.4% | 25,017 | +210.0% | 0.02% | +300.0% |
| Q4 2018 | $457,000 | -79.2% | 8,071 | -80.2% | 0.01% | -68.8% |
| Q3 2016 | $2,197,000 | -43.8% | 40,676 | -59.9% | 0.02% | -66.7% |
| Q3 2015 | $3,911,000 | -30.4% | 101,439 | -12.6% | 0.05% | -34.2% |
| Q2 2015 | $5,617,000 | +1025.7% | 116,061 | +789.7% | 0.07% | +942.9% |
| Q2 2014 | $499,000 | – | 13,045 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |